Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Revista Clinica Espanola|July 3, 2002
[Metastatic cáncer presentation. Validation of a diagnostic algorithm with 221 consecutive patients]F Losa Gaspà, J R Germá, J M Albareda, et al.
Hipertension Y Riesgo Vascular|March 12, 2021
[Cancer and cardiovascular risk]P Blanch Gracia, E Mena Sebastià, R Villanueva Vázquez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 3, 2021
Short-course radiotherapy in stage IV rectal cancer with resectable diseaseM Cambray, J González-Viguera, M Macià, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 13, 2017
SEOM clinical guideline on unknown primary cancer (2017)F Losa, G Soler, A Casado, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 2, 2016
SEOM Clinical Guideline of localized rectal cancer (2016)E González-Flores, F Losa, C Pericay, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 30, 2018
2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primaryF Losa, L Iglesias, M Pané, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 23, 2015
Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei)P Barrios, F Losa, S Gonzalez-Moreno, et al.
British Journal of Cancer|April 29, 2010
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancerJ Feliu, M J Safont, A Salud, et al.
British Journal of Cancer|March 23, 2006
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancerJ Feliu, A Salud, P Escudero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancerA Carrato, A Gómez, P Escudero, et al.
Pageof 3